Acadian Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-230,970
Closed -$3.38M 1837
2024
Q4
$3.38M Sell
230,970
-214,806
-48% -$3M 0.01% 633
2024
Q3
$5.59M Sell
445,776
-168,419
-27% -$1.83M 0.02% 479
2024
Q2
$5.22M Sell
614,195
-690,862
-53% -$6.15M 0.02% 483
2024
Q1
$13.7M Buy
1,305,057
+51,036
+4% +$567K 0.05% 246
2023
Q4
$13M Buy
1,254,021
+428,033
+52% +$3.41M 0.05% 251
2023
Q3
$5.23M Buy
825,988
+727,934
+742% +$5.38M 0.02% 428
2023
Q2
$846K Buy
+98,054
New +$878K ﹤0.01% 922
2020
Q3
Sell
-74,849
Closed -$2.7M 2386
2020
Q2
$2.7M Sell
74,849
-57,876
-44% -$2.13M 0.01% 648
2020
Q1
$4.71M Buy
+132,725
New +$5.43M 0.03% 407
2019
Q3
Sell
-233,472
Closed -$5.14M 2039
2019
Q2
$5.14M Buy
233,472
+69,337
+42% +$1.27M 0.02% 397
2019
Q1
$2.65M Buy
164,135
+50,736
+45% +$787K 0.01% 616
2018
Q4
$1.67M Buy
113,399
+29,468
+35% +$387K 0.01% 608
2018
Q3
$1.32M Buy
+83,931
New +$1.2M 0.01% 663
2018
Q2
Sell
-1,845
Closed -$23K 1866
2018
Q1
$23K Buy
+1,845
New +$20K ﹤0.01% 1472

Other funds holding ZYME

Acadian Asset Management's ZYME Position: Q1 2025 in Review

Acadian Asset Management sold out of Zymeworks (ZYME) in Q1 2025, closing a stake of 230,970 shares — an estimated $3.38M sold.

Acadian Asset Management first reported a position in ZYME in Q1 2018 and held it in 14 quarters. The position peaked at $13.7M in Q1 2024. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

  • Acadian Asset Management reported no remaining Zymeworks position as of Q1 2025 after selling out during the quarter.
  • Acadian Asset Management sold 230,970 Zymeworks shares in Q1 2025, an estimated $3.38M.
  • Acadian Asset Management first reported a position in Zymeworks in Q1 2018 and held it in 14 quarters.
  • Acadian Asset Management's Zymeworks position peaked at $13.7M in Q1 2024.
  • 184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Acadian Asset Management's 13F filing for Q1 2025, filed 21 May 2025.